VAERS 2127499
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge ER8727, EW0173
- Staat
- MD
- Alter
- -
- Geschlecht
- M
- Eingang
- 19.02.2022
- Impfdatum
- 01.04.2021
- Beginn
- 01.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Symptomtext
Headache, nausea and vomiting 42 hours past second dose- lasted for 7 hours.; Headache, nausea and vomiting 42 hours past second dose- lasted for 7 hours.; Headache, nausea and vomiting 42 hours past second dose- lasted for 7 hours.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 51 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Lot number: ER8727, EW0173) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer,, lot number=ER8727, EW0173,, lot unknown=False,, administration date=Apr/2021), administration date: Apr2021, when the patient was 51 years old, for COVID-19 immunisation, reaction(s): "lethargy", "soreness mild muscle aching". The following information was reported: HEADACHE (non-serious), NAUSEA (non-serious), VOMITING (non-serious) all with onset Apr2021, outcome "recovered" and all described as "Headache, nausea and vomiting 42 hours past second dose- lasted for 7 hours.". It was unknown if therapeutic measures were taken as a result of headache, nausea, vomiting. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -